HIV latency. Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 25011556.
- Also identified by DOI 10.1126/science.1256304 and PMC identifier 4230336.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Antiretroviral treatment (ART) of HIV infection suppresses viral replication. Yet if ART is stopped, virus reemerges because of the persistence of infected cells. We evaluated the contribution of infected-cell proliferation and sites of proviral integration to HIV persistence. A total of 534 HIV integration sites (IS) and 63 adjacent HIV env sequences were derived from three study participants over 11.3 to 12.7 years of ART. Each participant had identical viral sequences integrated at the same position in multiple cells, demonstrating infected-cell proliferation. Integrations were overrepresented in genes associated with cancer and favored in 12 genes across multiple participants. Over time on ART, a greater proportion of persisting proviruses were in proliferating cells. HIV integration into specific genes may promote proliferation of HIV-infected cells, slowing viral decay during ART.
Medical subject headings
- Genes, Neoplasm
- HIV Infections
- HIV-1
- Virus Integration
- Virus Latency